The MATISSE study: a randomised trial of group art therapy for people with schizophrenia

BMC Psychiatry

Study Protocol

Tony Soteriou¹  Katie Clayton²  Anna Maratos³  Thomas R Barnes⁴  Peter Tyrer⁴  Diana Waller⁴  Sue Patterson⁴  Mike J Crawford⁴  Francis A O'Neill⁵  Barbara Barrett⁶  Sarah Byford⁶  David Osborn⁷  Michael King⁷  Helen Killaspy⁷  Tony Johnson⁸  Eleftheria Kalaitzaki⁹ 

[1] Avon and Wiltshire Mental Health Partnership NHS Trust, Jenner House,Langley Park, SN15 1GG, Chippenham, UK;Camden and Islington NHS Foundation Trust, St Pancras Way, NW1 OPE, London, UK;Central and North West London NHS Foundation Trust, Hampstead Road, NW1 7QY, London, UK;Centre for Mental Health, Imperial College, Claybrook Road, W6 8LN, London, UK;Centre for Public Health, Queen's University, Grosvenor Road, BT12 6BA, Belfast, UK;Centre for the Economics of Mental Health, King's College London, De Crespigny Park, SE5 8AF, London, UK;Department of Mental Health Sciences, University College London, Pond Street, NW3 2QG, London, UK;MRC Biostatistics Unit, Cambridge and MRC Clinical Trials Unit, Robinson Way, CB2 0SR, Cambridge, UK;MRC General Practice Research Framework, North Gower Street, NW1 2ND, London, UK;

关键词: Schizophrenia;    Standard Care;    Global Functioning;    Group Facilitator;    Social Care Service;   

DOI  :  10.1186/1471-244X-10-65

 received in 2010-07-22, accepted in 2010-08-27,  发布年份 2010

来源: Springer

【 摘 要 】

BackgroundArt Therapy has been promoted as a means of helping people who may find it difficult to express themselves verbally engage in psychological treatment. Group Art Therapy has been widely used as an adjunctive treatment for people with schizophrenia but there have been few attempts to examine its effects and cost effectiveness has not been examined. The MATISSE study aims to evaluate the clinical and cost effectiveness of group Art Therapy for people with schizophrenia.Method/DesignThe MATISSE study is a three-arm, parallel group, pragmatic, randomised, controlled trial of referral to group Art Therapy plus standard care, referral to an attention control 'activity' group plus standard care, or standard care alone. Study participants were recruited from inpatient and community-based mental health and social care services at four centres in England and Northern Ireland. Participants were aged over 18 years with a clinical diagnosis of schizophrenia, confirmed by an examination of case notes using operationalised criteria. Participants were then randomised via an independent and remote telephone randomisation service using permuted stacked blocks, stratified by site. Art Therapy and activity groups were made available to participants once a week for up to 12 months. Outcome measures were assessed by researchers masked to allocation status at 12 and 24 months after randomisation. Participants and care givers were aware which arm of the trial participants were allocated to. The primary outcomes for the study are global functioning (measured using the Global Assessment of Functioning scale) and mental health symptoms (measured using the Positive and Negative Syndrome Scale) assessed at 24 months. Secondary outcomes were assessed at 12 and 24 months and comprise levels of group attendance, social function, satisfaction with care, mental wellbeing, and costs.DiscussionWe believe that this is the first large scale pragmatic trial of Art Therapy for people with schizophrenia.Trial registrationCurrent Controlled Trials ISRCTN46150447

【 授权许可】

CC BY   
© Crawford et al; licensee BioMed Central Ltd. 2010